My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about HOLX

BEDFORD, Mass., Dec. 17 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX) today announced that Rob Cascella, President and Chief Executive Officer, and Glenn Muir, Chief Financial Officer, will present at the 28th Annual J.P. Morgan Healthcare Conference, January 12, 2010, at 3:30 p.m. (Pacific).

Interested parties are invited to listen to a live audio webcast of Hologic's investor presentation on the investor section of the company's website at www.hologic.com/investor. An archive of the presentation will be available for replay following the conference.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications. For more information, visit www.hologic.com.

    Contact:     Deborah Gordon
                 Vice President, Investor Relations
                 Hologic, Inc.
                 (781) 999-7716

SOURCE Hologic, Inc.

RELATED LINKS
http://www.hologic.com